Jingyi Wang

5 papers in the catalog · China

Jingyi Wang: 5 papers in the catalog · China · Xiamen University, Xiang An Biomedicine Laboratory · Works on AbNovoBench, Fusion, SP-MEGD antibody sequencing

Affiliations

Elsewhere

ORCID 0000-0002-2287-541X · OpenAlex

Papers

XA-Novo: an accurate and high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures (2026, Nature Communications)
AbNovoBench: a resource and benchmarking platform for monoclonal antibody de novo sequencing (2026, bioRxiv)
XA-Novo: an accurate and high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures (2025, Research Square)
Simplified and Rapid Workflow Enhances Throughput of De Novo Sequencing of COVID-19 Neutralizing Antibodies (2024, bioRxiv)
Comprehensive assembly of monoclonal and mixed antibody sequences (2024, bioRxiv)

Methods and tools

AbNovoBench, Fusion, SP-MEGD antibody sequencing, XA-Novo

Co-authors (18)

Ranked by Newman fractional collaboration strength, so a pair on a two-author paper counts for more than a pair on a 50-author consortium paper.

Jin Xiao strength 0.47, 5 shared
Ning-Shao Xia strength 0.47, 5 shared
Quan Yuan strength 0.47, 5 shared
Rongshan Yu strength 0.47, 5 shared
Wenbin Jiang strength 0.47, 5 shared
Yueting Xiong strength 0.47, 5 shared
Ling Luo strength 0.36, 4 shared
Zhenjian Jiang strength 0.28, 3 shared
Qingfang Bu strength 0.26, 3 shared
Xiaoqing Chen strength 0.26, 3 shared
Yangtao Wu strength 0.26, 3 shared
Fan Liu strength 0.15, 2 shared
Yijie Qiu strength 0.15, 2 shared
Chao Wang strength 0.08, 1 shared
Lihong Huang strength 0.08, 1 shared
Sainan Zhang strength 0.08, 1 shared
Yiie Qiu strength 0.08, 1 shared
Zihan Lin strength 0.08, 1 shared

Seen in the charts

Back to the full map